Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53136

language	eng
Author	Chattopadhyay Subhayan a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany b Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Zheng Guoqiao a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany b Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Sud Amit Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Yu Hongyao a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany b Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Sundquist Kristina d Center for Primary Health Care Research, Lund University, Malmö, Sweden e Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA f Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Japan Sundquist Jan a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germanye Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA f Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Japan Foersti Asta a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany d Center for Primary Health Care Research, Lund University, Malmö, Sweden Hemminki Akseli g Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Finland h Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland Houlston Richard c Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK i Division of Molecular Pathology, The Institute of Cancer Research, London, UK Hemminki Kari a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany d Center for Primary Health Care Research, Lund University, Malmö, Sweden
Journal Title	LANCET HAEMATOLOGY
Volume	5
Issue	8
Start Page	E368
End Page	E377
ISSN	2352-3026
Published Date	2018-08
DOI	10.1016/S2352-3026(18)30108-X
PubMed ID	30075833
Publisher	ELSEVIER SCI LTD
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	Deutsche Krebshilfe, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, Swedish Research Council, ALF from Region Skane, and Bloodwise.